X-153693076-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000253122.10(SLC6A8):c.813C>T(p.Val271=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00329 in 1,209,832 control chromosomes in the GnomAD database, including 13 homozygotes. There are 1,348 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0025 ( 2 hom., 80 hem., cov: 24)
Exomes 𝑓: 0.0034 ( 11 hom. 1268 hem. )
Consequence
SLC6A8
ENST00000253122.10 synonymous
ENST00000253122.10 synonymous
Scores
1
3
7
Clinical Significance
Conservation
PhyloP100: 0.488
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0050970614).
BP6
Variant X-153693076-C-T is Benign according to our data. Variant chrX-153693076-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 379427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153693076-C-T is described in Lovd as [Likely_benign]. Variant chrX-153693076-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.488 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A8 | NM_005629.4 | c.813C>T | p.Val271= | synonymous_variant | 5/13 | ENST00000253122.10 | NP_005620.1 | |
SLC6A8 | NM_001142805.2 | c.813C>T | p.Val271= | synonymous_variant | 5/13 | NP_001136277.1 | ||
SLC6A8 | NM_001142806.1 | c.468C>T | p.Val156= | synonymous_variant | 5/13 | NP_001136278.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A8 | ENST00000253122.10 | c.813C>T | p.Val271= | synonymous_variant | 5/13 | 1 | NM_005629.4 | ENSP00000253122 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00250 AC: 282AN: 112803Hom.: 2 Cov.: 24 AF XY: 0.00229 AC XY: 80AN XY: 34951
GnomAD3 genomes
AF:
AC:
282
AN:
112803
Hom.:
Cov.:
24
AF XY:
AC XY:
80
AN XY:
34951
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00336 AC: 613AN: 182324Hom.: 9 AF XY: 0.00347 AC XY: 234AN XY: 67342
GnomAD3 exomes
AF:
AC:
613
AN:
182324
Hom.:
AF XY:
AC XY:
234
AN XY:
67342
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00338 AC: 3705AN: 1096974Hom.: 11 Cov.: 32 AF XY: 0.00350 AC XY: 1268AN XY: 362736
GnomAD4 exome
AF:
AC:
3705
AN:
1096974
Hom.:
Cov.:
32
AF XY:
AC XY:
1268
AN XY:
362736
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00248 AC: 280AN: 112858Hom.: 2 Cov.: 24 AF XY: 0.00228 AC XY: 80AN XY: 35016
GnomAD4 genome
AF:
AC:
280
AN:
112858
Hom.:
Cov.:
24
AF XY:
AC XY:
80
AN XY:
35016
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
8
ALSPAC
AF:
AC:
6
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
29
ExAC
AF:
AC:
400
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 27, 2021 | This variant is associated with the following publications: (PMID: 16738945) - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 22, 2018 | - - |
Creatine transporter deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 03, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 17, 2019 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
SLC6A8-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 07, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationTaster
Benign
D;D
PROVEAN
Benign
N
REVEL
Benign
Sift
Pathogenic
D
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at